Skip to main content

Table 2 Predicted mammographic measures in women 60 and 70 years old by menopausal hormone therapy use

From: Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study

 

PMD (%)

DA (cm2)

NDA (cm2)

Predicted (95% CI)

Predicted (95% CI)

Predicted (95% CI)

For a woman aged 60 years

 Never

24 (22 to 26)

24 (22 to 26)

78 (72 to 83)

 Past use

29 (27 to 31)

29 (26 to 31)

71 (66 to 76)

 Current use

33 (31 to 35)

33 (31 to 35)

67 (63 to 70)

For a woman aged 70 years

 Never

20 (18 to 23)

24 (21 to 27)

94 (87 to 101)

 Past use

25 (22 to 27)

29 (26 to 32)

87 (80 to 93)

 Current use

29 (26 to 32)

33 (30 to 37)

82 (75 to 89)

  1. PMD percent mammographic density, DA dense area, NDA non-dense area, MHT menopausal hormone therapy